B

BioCryst Pharmaceuticals
D

BCRX

7.57000
USD
0.18
(2.44%)
Market Closed
Volume
103,529
EPS
-0
Div Yield
-
P/E
-12
Market Cap
1,567,993,562
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    4.190
    (2.44%)
    175.700 USD
    AMGN
    AMGN
    2.27
    (0.87%)
    263.46 USD
    BMY
    BMY
    0.990
    (1.76%)
    57.280 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    MRK
    MRK
    -1.390
    (-1.40%)
    98.150 USD
    NVS
    NVS
    0.340
    (0.35%)
    97.070 USD
    PFE
    PFE
    0.595
    (2.31%)
    26.360 USD
    REGN
    REGN
    -5.64
    (-0.80%)
    702.60 USD
    VRTX
    VRTX
    0.58
    (0.15%)
    397.15 USD
    More
News

Title: BioCryst Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.